Related Experiment Video

Updated: May 28, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Pulling rabbits to reveal the secrets of the prion protein

Pedro Fernandez-Funez1, Yan Zhang, Jonatan Sanchez-Garcia

  • 1Department of Neurology University of Florida; Gainesville, FL USA.

Communicative & Integrative Biology
|October 8, 2011
PubMed

Insights

Prion protein (PrP) misfolding causes neurodegenerative diseases. Key residues in PrP structure influence susceptibility to prion disease, offering therapeutic targets.

Area of Science:

  • Neurobiology
  • Molecular Biology
  • Protein Chemistry

Background:

  • Prion protein (PrP) is central to neurodegenerative diseases.
  • Prion diseases are unique due to their infectious nature.
  • The 'protein-only' hypothesis posits misfolded PrP conformers (prions) cause disease.

Purpose of the Study:

  • To understand PrP conformational dynamics for therapy development.
  • To identify key residues in PrP that determine disease susceptibility.
  • To explore structural differences in PrP across various mammalian species.

Main Methods:

  • Comparative structural studies of PrP from susceptible and resistant mammals.
  • Transgenic studies utilizing PrP from different species.
  • Analysis of PrP residues influencing beta-structure conformation.

Main Results:

  • Structural and transgenic studies support differential susceptibility to prion disease in mammals.
  • Key PrP residues identified that dictate PrP structure.
  • These residues also influence the propensity to form a neurotoxic beta-structure.

Conclusions:

  • Understanding PrP conformational dynamics and species-specific structural variations is crucial for developing prion disease therapies.
  • Specific PrP residues are critical determinants of disease susceptibility and neurotoxicity.
  • Targeting these residues may offer a therapeutic strategy against prion diseases.
Keywords:
Drosophila modelsneurotoxicityprion diseasesprion proteinprotein structure

More Related Videos

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

Interview: Protein Folding and Studies of Neurodegenerative Diseases19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Protein Folding01:22

Protein Folding

Overview